DMRA Damora Therapeutics, Inc.

Fundamentals / CIK 0001800315 / USD

Damora Therapeutics, Inc. reported $532.6M in total assets and a net loss of $291.7M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DMRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$196.2MFY 2019 Net Income: -$36.51M2019FY 2020 Net Income: -$34.84M2020FY 2021 Net Income: -$51.75M2021FY 2022 Net Income: -$61.62M2022FY 2023 Net Income: -$38.35M2023FY 2024 Net Income: -$21.44M2024FY 2025 Net Income: -$209.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $26.88M $6.40M $23.77M $48.21M $38.49M $24.63M $19.74M
Total Operating Expenses $210.9M $22.26M $39.91M $61.21M $52.23M $33.64M $38.97M
Operating Income -$210.9M -$22.26M -$39.91M -$61.21M -$52.23M -$33.64M $38.97M
EBITDA -$210.8M -$22.24M -$39.64M -$61.16M -$52.21M -- --
Income Before Tax -$209.8M -$21.40M -$38.35M -$61.62M -$51.75M -$34.84M -$36.51M
Income Tax Expense $50K $41K $0 $0 $0 $0 $0
Net Income -$209.8M -$21.44M -$38.35M -$61.62M -$51.75M -$34.84M -$36.51M
Basic EPS $3.98 -$18.53 -$36.08 -$60.75 -$51.25 -$190.50 -$4,045.50
Diluted EPS $3.98 -$18.53 -$36.08 -$60.75 -$51.25 -$190.50 -$4,045.50
Basic Shares Outstanding 1.4M 1.2M 1.1M 1.0M 1.0M 182.9K 10.4K
Diluted Shares Outstanding 1.4M 1.2M 1.1M 1.0M 1.0M 182.9K 10.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $25.48M $25.54M $23.78M $23.32M $1.42M $1.47M $678K $1.01M
Total Operating Expenses $36.86M $34.99M $30.81M $201.7M $3.16M $3.42M $2.60M $7.10M
Operating Income -$36.86M -$34.99M -$30.81M -$201.7M -$3.16M -$3.42M -$2.60M -$7.10M
EBITDA -$36.86M -$34.99M -$30.81M -$201.7M -$3.15M -$3.42M -$2.59M -$7.10M
Income Before Tax -$31.99M -$30.92M -$27.74M -$200.7M -$3.13M -$3.43M -$2.53M -$6.75M
Income Tax Expense $0 $255K $42K $44K $0 $4.0K $2.0K --
Net Income -$31.99M -$31.17M -$27.78M -$200.7M -$3.13M -$3.44M -$2.53M -$6.74M
Basic EPS -$0.40 -$0.39 -$0.62 -- -$2.36 -$2.60 -$1.92 --
Diluted EPS -$0.40 -$0.39 -$0.62 -- -$2.36 -$2.60 -$1.92 --
Basic Shares Outstanding 61.8M 61.1M 34.3M -- 1.3M 1.3M 1.3M --
Diluted Shares Outstanding 61.8M 61.1M 34.3M -- 1.3M 1.3M 1.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $257.6M $14.18M $21.46M $32.79M $62.56M $163.6M $11.29M
Short-Term Investments $0 -- $11.69M $27.44M $37.63M -- --
Cash & Short-Term Investments $257.6M $14.18M $33.15M $60.22M $100.2M $163.6M $11.29M
Total Current Assets $260.4M $16.84M $36.77M $63.91M $110.1M $169.3M $56.08M
Property, Plant & Equipment, Net $36K $57K $78K $357K $203K -- --
Long-Term Investments -- -- -- $5.83M $9.05M -- --
Other Non-Current Assets $36K $163K $1.13M $2.28M $2.03M $1.16M --
Total Non-Current Assets $104K $293K $1.45M $9.28M $12.11M $2.30M $529K
Total Assets $260.5M $17.13M $38.23M $73.19M $122.2M $171.6M $56.61M
Accounts Payable $444K $377K $1.70M $3.35M $1.53M $2.85M $3.33M
Total Current Liabilities $20.07M $1.20M $5.83M $11.11M $4.54M $5.57M $7.93M
Other Non-Current Liabilities $28K $43K -- -- -- -- --
Total Non-Current Liabilities $81K $104K $66K $328K $448K $541K $211K
Total Liabilities $20.15M $1.30M $5.90M $11.44M $4.99M $6.11M $8.14M
Total Debt (incl. Leases) $68K $73K $249K $804K $846K $915K $298K
Retained Earnings -$487.4M -$277.5M -$256.1M -$217.7M -$156.1M -$104.4M -$69.52M
Accumulated Other Comp. Income $802K $97K $380K -$244K -$320K $674K -$2.45M
Total Stockholders' Equity $239.0M $14.47M $32.33M $61.75M $117.2M $165.5M -$71.15M
Total Equity $239.0M $14.47M $32.33M $61.75M $117.2M $165.5M -$71.15M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $349.7M $540.5M $532.9M $257.6M $7.61M $10.21M $11.94M $14.18M
Short-Term Investments $178.8M -- -- $0 -- -- -- --
Cash & Short-Term Investments $528.5M $540.5M $532.9M $257.6M $7.61M $10.21M $11.94M $14.18M
Total Current Assets $531.3M $543.6M $535.4M $260.4M $9.79M $13.03M $14.92M $16.84M
Property, Plant & Equipment, Net -- -- -- $36K $41K $47K $52K $57K
Other Non-Current Assets $480K $48K $34K $36K $837K $542K $317K $163K
Total Non-Current Assets $1.31M $48K $34K $104K $950K $664K $442K $293K
Total Assets $532.6M $543.6M $535.4M $260.5M $10.74M $13.69M $15.37M $17.13M
Accounts Payable $6.08M $3.48M $819K $444K $520K $756K $354K $377K
Total Current Liabilities $35.89M $27.55M $23.81M $20.07M $2.62M $2.63M $1.55M $1.20M
Other Non-Current Liabilities $28K $27K $27K $28K $49K $49K $45K $43K
Total Non-Current Liabilities $974K $27K $27K $81K $106K $109K $105K $104K
Total Liabilities $36.87M $27.58M $23.84M $20.15M $2.73M $2.74M $1.66M $1.30M
Total Debt (incl. Leases) $1.10M -- -- $68K $72K $75K $73K $73K
Common Stock $1.0K $1.0K $1.0K -- -- -- -- --
Retained Earnings -$578.3M -$546.3M -$515.1M -$487.4M -$286.6M -$283.5M -$280.1M -$277.5M
Accumulated Other Comp. Income -$233K $732K $754K $802K $823K $809K $300K $97K
Total Stockholders' Equity $495.8M $516.1M $511.6M $239.0M $6.67M $9.61M $13.71M $14.47M
Total Equity $495.8M $516.1M $511.6M $239.0M $6.67M $9.61M $13.71M $14.47M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$209.8M -$21.44M -$38.35M -$61.62M -$51.75M -$34.84M -$36.51M
Depreciation & Amortization $22K $21K $269K $42K $20K -- --
Stock-Based Compensation $998K $3.24M $5.43M $5.57M $4.48M $982K --
Change in Payables $51K -$1.32M -$1.65M $1.82M -$1.32M -$477K $1.94M
Operating Cash Flow -$6.73M -$18.62M -$36.91M -$42.93M -$52.31M -$38.20M -$19.33M
Capital Expenditure -- -- -- -$196K -$223K -- --
Free Cash Flow -- -- -- -$43.13M -$52.53M -- --
Acquisitions, Net -$17.37M -- -- -- -- -- -$326K
Purchases of Investments -- -- -$25.94M -$44.87M -$84.21M -- --
Investing Cash Flow -$17.37M $11.65M $22.33M $12.38M -$48.05M -- -$326K
Common Stock Issued -- -- $2.88M $507K -- -- --
Financing Cash Flow $266.8M -- $2.88M $507K -- $187.4M --
Net Change in Cash $242.7M -$6.97M -$11.71M -$30.04M -$100.4M $149.2M -$19.65M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$32.00M -$31.20M -$27.78M -$200.7M -$3.10M -$3.40M -$2.53M -$6.74M
Depreciation & Amortization $5.0K $6.0K $5.0K $6.0K $6.0K $6.0K $5.0K $5.0K
Stock-Based Compensation $7.54M $6.14M $3.13M $483K $164K $172K $179K $308K
Change in Payables $2.60M $2.66M $375K -$92K -$236K $402K -$23K -$126K
Operating Cash Flow -$17.23M -$21.87M -$20.60M $566K -$2.62M -$2.24M -$2.44M -$4.94M
Investing Cash Flow -- -- -- -- -- -- -- $0
Financing Cash Flow $5.12M $29.50M $295.9M -- -- -- -- --
Net Change in Cash -$190.9M $7.64M $275.3M $250.0M -$2.62M -$2.24M -$2.44M -$4.94M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -87.8% -148.2% -118.6% -99.8% -44.1% -21.1% --
Return on Assets (ROA) -80.5% -125.1% -100.3% -84.2% -42.3% -20.3% -64.5%
Current Ratio 12.98x 14.07x 6.31x 5.75x 24.23x 30.42x 7.07x
Quick Ratio 12.84x 11.84x 5.69x 5.42x 22.05x 29.39x 1.42x
Debt to Equity 0.00x 0.01x 0.01x 0.01x 0.01x 0.01x --
Operating Income Growth (YoY) -- -- -- -- -- -186.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -58.8% -50.9% -46.0% -87.8% -237.7% -172.6% -134.9% -148.2%
Return on Assets (ROA) -54.8% -48.3% -43.9% -80.5% -147.6% -121.2% -120.4% -125.1%
Current Ratio 14.80x 19.73x 22.48x 12.98x 3.73x 4.96x 9.62x 14.07x
Quick Ratio 14.72x 19.62x 22.38x 12.84x 2.90x 3.88x 7.70x 11.84x
Debt to Equity 0.00x -- -- 0.00x 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001800315) · from September 30, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:26 UTC · Open in terminal